en
Scientific article
Meta-analysis
Open access
English

Systemic corticosteroids for the management of cancer - related breathlessness (dyspnoea) in adults (Review)

Published inCochrane Database of Systematic Reviews, no. 2, CD012704
Publication date2019
Abstract

Dyspnoea is a common symptom in advanced cancer, with a prevalence of up to 70% among patients at end of life. The cause of dyspnoea is often multifactorial, and may cause considerable psychological distress and suffering. Dyspnoea is often undertreated and good symptom control is less frequently achieved in people with dyspnoea than in people with other symptoms of advanced cancer, such as pain and nausea. The exact mechanism of action of corticosteroids in managing dyspnoea is unclear, yet corticosteroids are commonly used in palliative care for a variety of non-specific indications, including pain, nausea, anorexia, fatigue and low mood, despite being associated with a wide range of adverse effects. In view of their widespread use, it is important to seek evidence of the effects of corticosteroids for the management of cancer-related dyspnoea.

Citation (ISO format)
HAYWOOD, Alison et al. Systemic corticosteroids for the management of cancer - related breathlessness (dyspnoea) in adults (Review). In: Cochrane Database of Systematic Reviews, 2019, n° 2, p. CD012704. doi: 10.1002/14651858.CD012704.pub2
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1469-493X
171views
73downloads

Technical informations

Creation11/18/2019 1:23:00 PM
First validation11/18/2019 1:23:00 PM
Update time03/15/2023 9:57:31 PM
Status update03/15/2023 9:57:30 PM
Last indexation01/17/2024 9:52:36 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack